CGT
ONC

Capital Guardian Trust’s BeOne Medicines Ltd ONC Stock Holding History

Capital Guardian Trust’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$89.6M Buy
722,294
+9,247
+1% +$1.17M 1.21% 18
2019
Q1 		$93.8M Buy
713,047
+374,286
+110% +$50.5M 1.25% 18
2018
Q4 		$47.5M Buy
+338,761
New +$44.9M 0.76% 49

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital Guardian Trust's ONC Position: Q2 2019 in Review

Capital Guardian Trust increased its BeOne Medicines Ltd (ONC) stake by 1.3% in Q2 2019, buying an estimated $1.17M and bringing the position to 722,294 shares worth $89.6M. The position accounts for 1.21% of the portfolio, ranked #18.

Capital Guardian Trust first reported a position in ONC in Q4 2018 and has held it in 3 quarters since. The position peaked at $93.8M in Q1 2019. 203 funds tracked by Wall St. Rank hold ONC as of Q2 2019.

  • Capital Guardian Trust held 722,294 shares of BeOne Medicines Ltd worth $89.6M as of Q2 2019.
  • Capital Guardian Trust bought 9,247 BeOne Medicines Ltd shares in Q2 2019, an estimated $1.17M.
  • BeOne Medicines Ltd made up 1.21% of Capital Guardian Trust's portfolio in Q2 2019, its #18 holding.
  • Capital Guardian Trust first reported a position in BeOne Medicines Ltd in Q4 2018 and has held it in 3 quarters since.
  • Capital Guardian Trust's BeOne Medicines Ltd position peaked at $93.8M in Q1 2019.
  • 203 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2019.

Based on Capital Guardian Trust's 13F filing for Q2 2019, filed 14 Aug 2019.